Suni Jani
Child & Adolescent Psychiatry · Columbia, MDNPI 1053671313
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 42.0% of the total. Among child & adolescent psychiatry clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 82 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$698
- Alkermes, Inc.$196
- Johnson & Johnson$119
- Neuronetics, Inc.$111
- Corium, LLC$102
- AbbVie$93
- plus $341 from 9 others
What the payments were for
- Food & beverage$1,60997%
- Education$503%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 37 | $698 |
| Alkermes, Inc. | 10 | $196 |
| Johnson & Johnson | 6 | $119 |
| Neuronetics, Inc. | 2 | $111 |
| Corium, LLC | 5 | $102 |
| AbbVie | 5 | $93 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Lundbeck LLC | 4 | $66 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $50 |
| Titan Pharmaceuticals, Inc. | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
| Orexo US, Inc. | 1 | $14 |
| Tris Pharma Inc | 1 | $14 |
| Indivior Inc. | 1 | $13 |
How this compares
$1,659 in reported general payments places this provider in the 90th percentile of 98 child & adolescent psychiatry providers in Maryland.
See all child & adolescent psychiatry providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 19 | $4,201 |
| Bupropion XlBupropion Hcl | 29 | $1,002 |
| Atomoxetine Hcl | 16 | $908 |
| Trazodone Hcl | 53 | $679 |
| Quetiapine Fumarate | 39 | $626 |
| Duloxetine Hcl | 18 | $418 |
| Aripiprazole | 20 | $308 |
| Escitalopram Oxalate | 12 | $174 |
| Lamotrigine | 29 | $173 |
| Mirtazapine | 11 | $164 |
| Sertraline Hcl | 14 | $140 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Columbia
- Sushma JaniColumbia$11K
- Diane StablerColumbia$534
- Valerie ShellColumbia$129
- Tolulope OmojokunColumbia$105
- Anna GonzagaBaltimore$180K
- Michael LabellarteTowson$92K
- Dejan BudimirovicBaltimore$10K
- Sabah HadiFrederick$7K
- Adefolake OshodiRockville$4K
- Jonathan ShepherdWoodlawn$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.